8-K
Current Report
Fulcrum Therapeutics, Inc. Filed Acc 0001047469-19-004324
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading a2239321z8-k.htm…